These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8499896

  • 1. Antibodies to Bordetella pertussis adenylate cyclase toxin in neonatal and maternal sera.
    Arciniega JL, Hewlett EL, Edwards KM, Burns DL.
    FEMS Immunol Med Microbiol; 1993 Apr; 6(4):325-30. PubMed ID: 8499896
    [Abstract] [Full Text] [Related]

  • 2. Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis.
    Arciniega JL, Hewlett EL, Johnson FD, Deforest A, Wassilak SG, Onorato IM, Manclark CR, Burns DL.
    J Infect Dis; 1991 Jan; 163(1):135-42. PubMed ID: 1984460
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.
    Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ.
    J Infect Dis; 2004 Jul 15; 190(2):335-40. PubMed ID: 15216470
    [Abstract] [Full Text] [Related]

  • 4. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.
    Lee SJ, Gray MC, Guo L, Sebo P, Hewlett EL.
    Infect Immun; 1999 May 15; 67(5):2090-5. PubMed ID: 10225859
    [Abstract] [Full Text] [Related]

  • 5. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.
    Grimprel E, Bégué P, Anjak I, Njamkepo E, François P, Guiso N.
    Clin Diagn Lab Immunol; 1996 Jan 15; 3(1):93-7. PubMed ID: 8770511
    [Abstract] [Full Text] [Related]

  • 6. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J.
    Vaccine; 2004 Oct 22; 22(31-32):4270-81. PubMed ID: 15474718
    [Abstract] [Full Text] [Related]

  • 7. Western blot analysis of antibody responses of young infants to pertussis infection.
    Guiso N, Grimprel E, Anjak I, Bégué P.
    Eur J Clin Microbiol Infect Dis; 1993 Aug 22; 12(8):596-600. PubMed ID: 8223658
    [Abstract] [Full Text] [Related]

  • 8. [A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine].
    Zakharova NS, Shmeleva EI, Remova TN, Bazhanova IG, Ozeretskovskaia MN, Mertsalova NU, Britsina MV, Ermolova EV, Zaĭtsev EM.
    Zh Mikrobiol Epidemiol Immunobiol; 1997 Aug 22; (3):70-2. PubMed ID: 9304336
    [Abstract] [Full Text] [Related]

  • 9. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.
    Weiss AA, Hewlett EL, Myers GA, Falkow S.
    J Infect Dis; 1984 Aug 22; 150(2):219-22. PubMed ID: 6088647
    [Abstract] [Full Text] [Related]

  • 10. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants.
    Gonik B, Puder KS, Gonik N, Kruger M.
    Infect Dis Obstet Gynecol; 2005 Jun 22; 13(2):59-61. PubMed ID: 16011994
    [Abstract] [Full Text] [Related]

  • 11. The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin.
    Betsou F, Sebo P, Guiso N.
    Infect Immun; 1995 Sep 22; 63(9):3309-15. PubMed ID: 7642260
    [Abstract] [Full Text] [Related]

  • 12. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.
    Khelef N, Danve B, Quentin-Millet MJ, Guiso N.
    Infect Immun; 1993 Feb 22; 61(2):486-90. PubMed ID: 8423077
    [Abstract] [Full Text] [Related]

  • 13. Maternally derived antibodies against Bordetella pertussis antigens pertussis toxin and filamentous hemagglutinin in preterm and full term newborns.
    Heininger U, Riffelmann M, Leineweber B, Wirsing von Koenig CH.
    Pediatr Infect Dis J; 2009 May 22; 28(5):443-5. PubMed ID: 19319020
    [Abstract] [Full Text] [Related]

  • 14. Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection.
    Khelef N, Sakamoto H, Guiso N.
    Microb Pathog; 1992 Mar 22; 12(3):227-35. PubMed ID: 1614333
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice.
    Hormozi K, Parton R, Coote J.
    FEMS Immunol Med Microbiol; 1999 Apr 22; 23(4):273-82. PubMed ID: 10225286
    [Abstract] [Full Text] [Related]

  • 16. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB.
    Clin Infect Dis; 1999 Mar 22; 28(3):552-9. PubMed ID: 10194077
    [Abstract] [Full Text] [Related]

  • 17. Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.
    Scanlon K, Skerry C, Carbonetti N.
    Adv Exp Med Biol; 2019 Mar 22; 1183():35-51. PubMed ID: 31376138
    [Abstract] [Full Text] [Related]

  • 18. Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination.
    Thomas MG, Redhead K, Lambert HP.
    J Infect Dis; 1989 Feb 22; 159(2):211-8. PubMed ID: 2536779
    [Abstract] [Full Text] [Related]

  • 19. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus.
    van Gageldonk PG, van Schaijk FG, van der Klis FR, Berbers GA.
    J Immunol Methods; 2008 Jun 01; 335(1-2):79-89. PubMed ID: 18407287
    [Abstract] [Full Text] [Related]

  • 20. Induction of macrophage apoptosis by Bordetella pertussis adenylate cyclase-hemolysin.
    Khelef N, Guiso N.
    FEMS Microbiol Lett; 1995 Dec 01; 134(1):27-32. PubMed ID: 8593951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.